Stock listing
Keros Therapeutics, Inc.
Selected listing: KROS · NASDAQ · USD · US
Keros Therapeutics, Inc. (NASDAQ:KROS), Health Technology. Latest release Sep 29, 2026: Keros Therapeutics to Receive Additional Development Milestone Payment…
- Ticker
- NASDAQ:KROS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Keros Therapeutics, Inc.
Keros Therapeutics, Inc. is a public company trading under the ticker KROS in the American market. Keros focuses on developing innovative therapies for patients with rare diseases and unmet medical needs.
Latest news from Keros Therapeutics, Inc.
Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda
September 28, 2026
Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD
September 28, 2026
Keros Therapeutics Announces $5 Million Share Repurchase Authorization
September 8, 2026
Keros Therapeutics Reports Second Quarter 2026 Financial Results
August 3, 2026
Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
July 30, 2026
Research Keros Therapeutics, Inc.
Keros Therapeutics, Inc. company profile
View the public company page for Keros Therapeutics, Inc. on 6ix.
Keros Therapeutics, Inc. news
Read company news and market updates connected to Keros Therapeutics, Inc..
Keros Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Keros Therapeutics, Inc..